Genetic inactivation of a number of other proinflammatory factors, including IκB kinase, interleukin-6, and STAT3 (20–22), similarly shows reduced tumor incidence in the AOM-DSS model, but none prevent tumor formation entirely when inactivated. The gene discussed is IL6; the disease is neoplasm.